Background
==========

The cellular proteome (the total protein repertoire, which includes how each protein may be co-translationally or post-translationally modified) is affected by numerous stresses, including infection by viruses. Numerous previous microarray studies have determined how cellular transcriptomes respond after virus infection (see for example: \[[@B1],[@B2]\]). However, since mRNA levels cannot provide complete information about levels of protein synthesis or the types and degrees of post-translational modifications, there frequently is little concordance between microarray and protein data \[[@B3]-[@B5]\]. Therefore, quantitative and comparative proteomic analyses are also being used to provide additional information about host alterations to virus infection (reviewed in: \[[@B6],[@B7]\]). Commonly used methods include 2-dimensional difference in gel electrophoresis (2D-DIGE (see for examples: \[[@B8],[@B9]\]), isotope coded affinity tags (ICAT; \[[@B10],[@B11]\]), isobaric tags for relative and absolute quantitation (iTRAQ; \[[@B12],[@B13]\]), and stable isotope labeling by amino acids in cell culture (SILAC; \[[@B14]-[@B18]\]). The SILAC method involves labeling cells with "light" (normal; **L**) and "heavy" (**H**) isotopic forms of amino acids. Advantages of this particular technique include: experimental set-up is relatively simple, **L** and **H** samples are mixed together early in this process, thereby reducing sample-to-sample variability, and, if ^12^C~6~-Lys and ^12^C~6~^14^N~4~-Arg (**L**), and ^13^C~6~-Lys and ^13^C~6~^15^N~4~-Arg (**H**) amino acids are used, virtually every tryptic peptide should contain a labeled amino acid, thereby providing increased protein coverage. Indeed, several early comparative studies suggested SILAC provided more identifications than the other commonly used methods (reviewed in \[[@B7]\]). We have been using SILAC to measure comparative proteomic alterations induced by influenza virus in A549 \[[@B19]\] and in normal human bronchial epithelial (NHBE) airway cells \[[@B20]\]. We have also begun similar analyses with reovirus-infected cells, focusing initially upon reovirus serotype T1L-infected HEK-293 cells \[[@B21]\].

The mammalian reoviruses (MRV) are non-enveloped viruses with a genome that consists of 10 segments of double-stranded (ds)RNA. The dsRNA genome is enclosed in a double-layered concentric protein capsid composed of 8 viral structural proteins. For reviews, see \[[@B22]-[@B24]\]. MRV is the prototype member of the Orthoreovirus genus in the family *Reoviridae*. The Ortheoreoviruses include nonfusogenic MRV and fusogenic avian reovirus. The Reoviridae family also contains rotaviruses \[[@B25]\], orbiviruses \[[@B26]\], and at least 9 other genera, several of which can infect animals, insects and/or plants \[[@B23],[@B24]\]. MRV infections are generally mild in humans but many of the other family members are highly pathogenic in their hosts. MRV currently consist of 4 identified serotypes, with each represented by a prototype strain: strain Lang (T1L) for serotype 1; strain Jones (T2J) for serotype 2, strain Dearing (T3D) for serotype 3 and strain Ndelle for serotype 4 \[[@B27]\]. The reoviruses have long served as models for understanding viral pathogenesis \[[@B22]\] and they have also been identified as potential oncolytic agents \[[@B28]-[@B30]\] because of their capacity to selectively kill cancer cells that contain activated Ras pathway and functional p53 \[[@B28],[@B31]\].

MRV are capable of infecting a wide range of cells, including mouse L929 cells, often used for stock preparation and titration \[[@B32]\], and various human cells, including HEK-293 \[[@B21]\]. Numerous reovirus studies have also been performed in HeLa cells (see for examples: \[[@B33]-[@B36]\]). Global microarray analyses of MRV-infected cellular transcriptomes detected activation of numerous cellular genes, including many related to apoptosis \[[@B37]-[@B41]\]. These microarray assays have recently been complemented by quantitative and comparative proteomic analyses. For example, Li and colleagues recently demonstrated, using 2D-DIGE, that MRV-infected murine myocytes regulate several proteins, including heat shock proteins and interferon-response proteins \[[@B42]\]. We have also shown, using SILAC and 2D-HPLC/MS, that proteins involved in cell death, cell growth and proliferation, molecular transport, gene expression, and inflammatory response pathways are affected in MRV T1L-infected HEK-293 cells \[[@B21]\]. Similar pathways were also found regulated in a preliminary analysis of reovirus T3D-infected HeLa cells that concluded that inclusion of Proteominer® bead-based non-biased enrichment did not significantly improve proteomic coverage of unpurified cell extracts \[[@B43]\].

Thus, as part of an ongoing systematic delineation of reovirus-induced comparative host protein responses, we are examining how reoviruses T1L and T3D, two of the most commonly used MRV strains, affect various permissive cells. We have extended our previous T1L-infected HEK-293 cell study \[[@B21]\] to T3D-infected HEK-293 cells (Berard, in preparation). Our previous proteomic analysis of HeLa cells infected with T3D concluded that inclusion of Proteominer® bead-based non-biased enrichment did not significantly improve proteomic coverage of unpurified cell extracts \[[@B43]\]. Therefore, the current study extends these previous studies by examining proteomic alterations in purified cytosolic and nuclear fractions in order to globally assess sub-cellular protein distribution. Reciprocal labeling also was incorporated to identify probable contaminants which were removed from the analyses. We also extended previous protein identification by more detailed follow-up kinetic studies of some selected important proteins. This study identified and measured 2856 cytosolic proteins by 2 or more peptides at \>99% confidence and 884 nuclear proteins. DAVID™ and IPA™ ontological analyses identified significantly up- and down-regulated proteins as well as significantly affected canonical pathways.

Materials and methods
=====================

Cells and viruses
-----------------

### Cell lines and media

Mouse L929 fibroblast cells (L929) were grown in suspension in Joklik's modified minimal essential medium (J-MEM) (Gibco, Grand Island, NY) supplemented to contain 5% fetal bovine serum (FBS) (Invitrogen Canada Inc., Burlington, Ontario), and 2 mM L-glutamine as described \[[@B32]\]. Cells were sub-cultured daily.

Human HeLa cells were cultured as monolayers in Dulbecco's modified MEM (D-MEM) supplemented with 0.2% (w/v) glucose, 10% FBS (Invitrogen), 2 mM l-glutamine, non-essential amino acids, and sodium pyruvate. Cells were sub-cultured 2 -- 3 times each week.

### Viruses

Reovirus strain Type 3 Dearing (T3D) is a laboratory stock. There are two commonly-used clones of T3D; the Cashdollar strain (T3D^C^) and the Fields strain (T3D^F^). We elected to use the T3D^F^ strain because a large number of genetic reagents, including temperature-sensitive mutants (reviewed in \[[@B44],[@B45]\]) and T1L/T3D^F^ intertypic reassortants \[[@B46]-[@B48]\] were generated from this clone. Virus stocks were usually grown in L929 cell monolayers in J-MEM in the presence of 5% CO~2~ at 37°C as above, but with 3% FBS, 100 U/ml of penicillin, 100 μg/ml streptomycin sulfate and 100 μg/ml amphotericin-B as previously described \[[@B32]\].

### Virus purification

Large quantities of reovirus T3D were grown in suspension L929 cell cultures and purified by routine procedures that make use of Vertrel-XF™ extraction and cesium chloride ultracentrifugation \[[@B49]\]. Purified virions were harvested and dialyzed against D-Buffer (150 mM NaCl, 15 mM MgCl~2~, 10 mM Tris, pH 7.4). Virus concentration was measured by optical density at 260 nm, using the relationship 1 ODU = 2.1 × 10^12^ particles per milliliter \[[@B34]\] and infectivity was titrated.

Infections
----------

Sets of HeLa cells were infected with gradient-purified T3D at a multiplicity of infection (MOI) of 7 PFU per cell. For routine infections not destined for SILAC analysis (i.e. for photomicrography, virus growth kinetic determinations, or Western blot analyses -- see below), cells were harvested at various time points (0 -- 72 hours post infection; hpi), then fractionated as described below.

For SILAC labeling, HeLa cells were adapted through 3 passages (=6 doublings) into D-MEM media provided in a SILAC™ Phosphoprotein Identification and Quantification Kit (Invitrogen Canada Inc.; Burlington, Ontario), supplemented as above (except without non-essential amino acids), and with 10% dialyzed FBS (Invitrogen), plus 100mg each of normal (**L**; ^12^C~6~-lysine and ^12^C~6~-/^14^N~4~-arginine) or "heavy" (**H**; ^13^C~6~-lysine \[6.0Da difference\] and ^13^C~6~-/^15^N~4~-arginine \[10.0Da\] difference) per liter of D-MEM. Once HeLa cells had grown through six doublings in appropriate SILAC media, sets of cells were infected with gradient-purified T3D or were mock infected with diluent. Cells were overlaid with appropriate SILAC media and cultured for 24 hours. In one experiment (Run \#1) the **L** cells were infected and the **H** cells were mock infected, whereas **H** cells were infected and **L** cells were mock infected in the reciprocal labeling experiment (Run \#2).

Microscopy
----------

HeLa cells were allowed to attach to 6-well culture dishes or onto sterile glass cover slips in 6-well culture dishes and incubated overnight at 37°C. Cells, at approximately 70% confluency, were washed twice with 1X PBS and T3D was added to each culture at an MOI of 7. Virus was adsorbed to cells on ice for one hour to ensure infection synchronization. Mock-infected cells received only diluent. Cells were overlaid with complete pre-warmed media and cells were then incubated for various periods of time from 0 to 72 hours at 37°C.

Infections were monitored at various times and aliquots taken for cell viability determinations, using trypan blue and ensuring \> 200 cells were counted at each time point, and for virus titrations. Cell monolayers were also examined with a Nikon TE-2000 and cells were photographed with a Canon-A700 digital camera. Images were imported into Adobe and slight adjustments made in brightness and contrast, but which did not alter image context with respect to each other.

Cell fractionation
------------------

Infected and mock-infected cells were harvested at various times post-infection and counted. Aliquots of each culture were saved for virus titration to verify infection status. Non-SILAC-labeled cells were individually processed. For comparative SILAC assays, equivalent numbers of **L** and **H** cells in each experimental run were confirmed to contain equivalent amounts of protein by BCA™ Protein Assay (Pierce; Rockford, IL) and were mixed together 1:1. Harvested cells were washed 3× in \>50 volumes of ice-cold Phosphate Buffered Saline (PBS). Washed cells were resuspended in 250 μl of ice-cold PBS supplemented with 1.5× complete™ Protease Inhibitor (Pierce) and lysed by the addition of 1/10^th^ volume of 5% NP-40. Cells were incubated for 30 min with periodic mixing then centrifuged at 500×g for 10 min to pellet nuclei. The supernatants (cytosol and soluble membranes) were transferred to fresh microfuge tubes and the nuclear pellets were resuspended in 250 μl of PBS supplemented with 1× complete™ Protease Inhibitor + 10% sucrose + 0.44% NP-40 and nuclei re-pelleted, with the 2^nd^ supernatants added to the first ones. The nuclei were then washed 4 times with 1ml of PBS + 0.25× complete™ Protease Inhibitor + 10% sucrose. Washed nuclei were extracted by a new 2-step MS-compatible procedure \[[@B20]\]. Briefly, nuclei were resuspended in 150 μl of High Salt Extraction Buffer (620 mM NaCl, 1 mM DTT, 1 mM MgSO~4~, 10 mM HEPES, pH 8.0), freeze-thawed, sonicated, insoluble material pelleted at 17,000×g for 10 min, and the supernatants transferred to fresh microfuge tubes. The insoluble pellets were resuspended in 50 μl of 8 M urea, freeze-thawed, sonicated, insoluble material pelleted at 17,000×g for 10 min, and the 2^nd^ supernatants combined with the first.

Protein content in each fraction was determined by BCA Protein Assay (Pierce) and bovine serum albumin standards. The cytosolic and nuclear fractions were stored at -80°C until further processing took place.

Immunoblotting
--------------

Equivalent cytosolic and nuclear fractions were resolved by either 10% linear mini sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE, (8.0 × 6.5 × 0.1 cm)) at 180 V for 60 min. or in 4-16% gradient SDS-PAGE (8.0 × 16.0 × 0.1 cm) at 20 mA per gel for 5.5 hours (or overnight for a cumulative total of 110 mAhr per gel). Proteins were transferred to 0.2 μm polyvinylidene difluoride (PVDF) membranes at 20 V for 40 min with a Semi-dry apparatus (BioRad), and protein transfer was confirmed by Ponceau-S staining. The membranes were blocked with 5% (w/v) skim milk in Tris-buffered saline with Tween-20 (TBST; 50 mM Tris, 150 mM NaCl, 0.05% Tween 20, pH 7.4) and probed with various primary antibodies. Primary antibodies were: in-house produced rabbit anti-reovirus, α- GAPDH (Cell Signaling, cat\#2118), α-Mx1 (Ori-Gene \# TA308496), α-PARP (Cell Signaling, cat\#9541), α-ISG15 (Rockland, cat\#200-401-438), α-IFIT (Abcam, cat\#ab55837), and α-SAMD9 (Sigma, cat\#HPA021318); and mouse α-Actin (Sigma, cat\#A5441) and anti-STAT1 (Cell Signaling, cat\#9176). Appropriate secondary horseradish peroxidase (HRP)-conjugated rabbit anti-mouse or goat anti-rabbit (Cell Signaling, cat\#7076, cat\#7074, respectively) were used to detect immune complexes. Bands were developed by enhanced chemiluminescence and imaged with an Alpha Innotech FluorChemQ MultiImage III instrument.

Comparative SILAC analyses
--------------------------

### Protein digestion and peptide fractionation

After protein concentration determinations, SILAC-labeled samples were diluted with freshly made 100 mM ammonium bicarbonate to concentrations of \~1 mg/ml and pH \~8. Three hundred μl of each sample (\~300 μg of protein) were reduced with dithiothreitol (DTT), alkylated with iodoacetic acid, quenched with additional DTT, and trypsin-digested overnight at 37°C with 6 μg of sequencing grade trypsin (Promega, Madison, WI) as previously described \[[@B19]\]. Digests were dried.

Tryptic peptides were fractionated by an orthogonal 2-dimensional reverse-phase (RP) high pH -- RP low pH procedure \[[@B50],[@B51]\]. Lyophilized tryptic digests were dissolved in 200 μl of 20 mM ammonium formate pH 10 (Buffer A), injected onto a 1×100 mm XTerra (Waters, Milford, MA) column and fractionated with a 0.67% acetonitrile per minute linear gradient (Agilent 1100 Series HPLC system, Agilent Technologies, Wilmington, DE) at a flow rate of 150 μL/min. Sixty 1-min fractions were collected (covering \~40% acetonitrile concentration range) and concatenated \[[@B51],[@B52]\], with the last 30 fractions combined with the first 30 fractions in sequential order (i.e. \#1 with \#31; \#2 with \#32, etc.). Combined fractions were vacuum-dried and re-dissolved in buffer A for the second dimension RP separation (0.1% formic acid in water).

A splitless nano-flow Tempo LC system (Eksigent, Dublin, CA) with 20 μL sample injection via a 300 μm×5 mm PepMap100 pre-column (Dionex, Sunnyvale, CA) and a 100 μm×200 mm analytical column packed with 5 μm Luna C18(2) (Phenomenex, Torrance, CA) were used in the second dimension separation prior to MS analysis. Both eluents A (water) and B (acetonitrile) contained 0.1% formic acid as an ion-pairing modifier. A 0.33% acetonitrile per minute linear gradient (0-30% B) was used for peptide elution, providing a total 2-hour run time for each of the 30 concatenated samples.

### Mass spectrometry, bioinformatics, and data mining

A QStar Elite mass spectrometer (Applied Biosystems, Foster City, CA) was used in a data-dependent MS/MS acquisition mode. One-second survey MS spectra were collected (m/z 400-1500) followed by MS/MS measurements on the 3 most intense parent ions (80 counts/sec threshold, +2 - +4 charge state, m/z 100-1500 mass range for MS/MS), using the manufacturer's "smart exit" (spectral quality 5) settings. Previously targeted parent ions were excluded from repetitive MS/MS acquisition for 60 sec (50 mDa mass tolerance) and the bias correction option was used to correct for small pipetting errors. Raw data files (30 for each of the 4 experimental run samples) were submitted for simultaneous search using standard SILAC settings for QStar instruments and were analyzed by Protein Pilot®, version 4.0, using the non-redundant human gene database (NCBInr, released March 2011, downloaded from <http://ftp.ncbi.nih.govrefseqH_sapiensmRNA_Prot>, containing 37,391 entries). Proteins, their confidences, and their expression ratios, expressed as infected: mock (I:M), were returned with gi accession numbers. Only proteins for which at least 2 fully trypsin digested **L** and **H** peptides were detected at \>99% confidence were used for subsequent comparative quantitative analyses. The false discovery rate (FDR), defined as the percentage of reverse proteins identified against the total protein identification, was determined to be \< 0.8%.

Each of the 4 datasets were normalized, essentially as described \[[@B53]\] to allow dataset merging and comparison. Briefly, every I:M ratio was converted into log space to determine geometric means and standard deviations in each dataset. Every protein's log~2~ I:M ratio was then converted into a z-score, using the formula:

$$Z - \text{score}\left( \sigma \right)\ {of}\ \left\lbrack b \right\rbrack = \frac{\begin{matrix}
{{Log}_{2}I:M\left\lbrack b \right\rbrack –{Average}\ {of}} \\
{\ \left( {\log_{2}\ \text{of}\ \text{each}\ \text{member},a\ldots.n} \right)} \\
\end{matrix}}{\begin{matrix}
{\text{Standard}\ \text{deviation}\ \text{of}} \\
{\ \left( {\log_{2}\ \text{of}\ \text{each}\ \text{member},a\ldots.n} \right)} \\
\end{matrix}}$$

where "b" represents an individual protein in a dataset population a....n, and z-score is the measure of how many standard deviation units (expressed as "σ") that protein's log~2~ I:M ratio is away from its population mean. Thus, a protein with a z-score \> 1.960σ indicates that protein's differential expression lies outside the 95% confidence level, \> 2.576σ indicates outside the 99% confidence level, and 3.291σ indicates 99.9% confidence. Z-scores \>1.960 were considered significant. Proteins that obtained significant positive z-scores in one labeling experiment, but that also obtained significant negative z-scores in the reciprocal labeling experiment were assumed to be contaminants, were removed from analysis, and z-scores iteratively re-calculated. Gi numbers of all significantly regulated proteins were converted into HGNC identifiers by Uniprot (<http://www.uniprot.org/>) and HGNC terms were submitted to and analyzed by STRING \[[@B54],[@B55]\] and by the DAVID bioinformatic suite at the NIAID, version 6.7 \[[@B56],[@B57]\] and gene ontologies examined with the "FAT" datasets. The gi numbers were also submitted to, and pathways constructed with, Ingenuity Pathway Analysis software (IPA™).

Results and discussion
======================

T3D replicates in HeLa cells
----------------------------

Reoviruses are routinely cultured and titrated in mouse L929 cells \[[@B22],[@B23]\]. The virus also is capable of growing in HeLa cells \[[@B35]\]. We evaluated the time course and confirmed the capacity of T3D to enter and replicate in HeLa cells, and to cause cytopathic effect (CPE), under various infection conditions (Figure [1](#F1){ref-type="fig"}). Phase-contrast microscopy indicated mock-infected cells showed no evidence of virus infection and CPE was not noticeable until almost a week later, presumably due to nutrient deprivation. T3D-infected HeLa cells also showed little, if any, noticeable CPE until approximately 72 hpi (Figure [1](#F1){ref-type="fig"}A). Differences in CPE were detectable by trypan blue exclusion, with mock-infected cells showing gradual loss of cell viability from 0 to 72 hpi (Figure [1](#F1){ref-type="fig"}B). Differences in trypan blue-measured cell viability between the mock- and T3D-infected samples began to manifest at 24 hpi and became more apparent later (Figure [1](#F1){ref-type="fig"}B). Virus titers initially declined, corresponding to virus uncoating, and began to increase after 6 hpi, was exponential from 6 to 36 hpi, and plateaued after this point. Thus, we elected to use an initial MOI of 7, the same amount of virus used in our earlier quantitative proteomic analyses \[[@B19]-[@B21]\], and to examine comparative quantitative differences at the 24 hpi time point, prior to significant CPE development, to allow more meaningful comparison to these other studies.

![**Confirmation of HeLa cell infectivity. A**, HeLa cells were mock-infected (top), or infected with MRV strain T3D at an MOI of 7 (bottom). Cells were imaged at indicated times post-infection (labeled at top) with a Nikon TE-2000 inverted microscope and photographed with a Canon A700 digital camera. Images were imported into Adobe and slight adjustments made in brightness and contrast, that did not alter image context. Scale bar is 50 μm. **B**, Kinetics of virus production (▼) and cell viability after HeLa cells were infected (○) or mock-infected (●) with T3D. Error bars represent standard error of the mean from 2 or more replicates.](1743-422X-10-202-1){#F1}

Identification of altered host proteins
---------------------------------------

HeLa cells were infected (or mock) in duplicate and purified cytosolic and nuclear fractions obtained. Viruses generally induce profound alterations in infected cells. To rule out the possibility that infection might lead to profound alterations, including significant nuclear leakage by 24 hpi, which could affect our interpretations of protein localization, we determined the distribution of annotated nuclear proteins within each of our **L**-labeled cytoplasmic fractions (Additional file [1](#S1){ref-type="supplementary-material"}: Figure S1). 922 of the 2137 (43.1%) **L**-labeled proteins in the mock-infected cytoplasmic sample had GO nuclear annotations, whereas 43.6% of the 1583 **L**-labeled proteins in the infected cytoplasmic sample had GO nuclear annotations, suggesting no significant nuclear leakage by 24 hpi in the infected samples. 2D-HPLC/MS processing of the mixed samples identified 73,969 **H:L** peptide pairs, corresponding to 3230 proteins, at ≥99% confidence. 2067 proteins were found in the cytosolic fraction in experimental run \#1 and 2787 were present in the run \#2 cytosolic fraction (Table [1](#T1){ref-type="table"}). Exclusion of those proteins identified by only a single peptide, as well as those that probably represent contaminants (see next paragraph), further reduced the number of identified proteins to 1981 in the run \#1 cytosolic fraction (Table [1](#T1){ref-type="table"}; Figure [2](#F2){ref-type="fig"}A). Using similar criteria, we analyzed 2651 proteins in the reciprocally-labeled cytosolic fraction (run \#2) and 653 and 711 nuclear proteins (Table [1](#T1){ref-type="table"}; Figure [2](#F2){ref-type="fig"}A).

![**Distributions of proteins identified in various experiments. A**, Venn diagram of numbers of identified proteins from various analyses. **B**, Frequency distributions of identified proteins in both cytosolic sample sets, with I:M ratios expressed as Log~2~ values. Positive values represent up-regulated host proteins in virus-infected cells; negative values represent down-regulated host proteins. **C**, Frequency distributions of identified proteins in both nuclear sample sets. Note that distributions are not identical, with different numbers of proteins differentially expressed away from the major central peak. Characteristics of all peptide and protein distributions, mean log~2~ I:M ratios and standard deviations of log~2~ I:M ratios are shown in Table [1](#T1){ref-type="table"}.](1743-422X-10-202-2){#F2}

###### 

**Number of peptides, proteins, log**~**2**~**Infected: Mock (I:M) ratio means and standard deviation, and Z-scores of SILAC-measured HeLa cell proteins after T3D infection**

                                                             **Cytosol**   **Nuclei**           
  --------------------------------------------------------- ------------- ------------ -------- --------
                           Total number of peptide pairs^1^    22,591        34,393     8,011    8,974
                                Total number of proteins^2^     2,067        2,787       670      728
                             Number of proteins analysed^3^     1,987        2,684       635      686
                                     Mean Log~2~ I:M ratios    0.0147        0.0126     0.0004   0.0187
                    Standard deviation of Log~2~ I:M ratios    0.3382        0.4211     0.4664   0.3423
    Number of proteins at Z-score cutoff of: ± 1.960σ (95%)   33, 22^4^      50, 20      7, 4    20, 12
                                             ± 2.576σ (99%)    24, 11        29, 11      5, 2    14, 8
                                           ± 3.291σ (99.9%)     14, 7        23, 8       2, 2     8, 4

^1^ Total number of H:L peptide pairs for all proteins identified at confidence level ≥ 99%.

^2^ Total number of proteins identified at confidence level ≥ 99%.

^3^ Number of proteins analyzed after those identified by only a single peptide, as well as possible contaminants, removed.

^4^ First value is number of up-regulated proteins outside the indicated confidence level; second number is number of down-regulated proteins outside the indicated confidence level.

Each protein's infected-to-mock (I:M) **H:L** or **L:H** ratio was converted into a z-score to normalize the data and facilitate comparisons of each dataset as described in Materials and Methods (and in \[[@B19]\]). A number of proteins were found to have significantly high or low log~2~ values and corresponding z-scores in either the **H:L** or **L:H** labeling scheme, but z-scores that were significantly regulated in the opposite direction in the reciprocal labeling experiment. These included hornerin, keratins, some S100 calcium-binding proteins, and some other proteins (Additional file [2](#S2){ref-type="supplementary-material"}: Table S1; rows 3111-3243). These significant reciprocal values could arise if, for example, exogenous unlabeled (= **L**-labeled) proteins were introduced during processing. Thus, such proteins were assumed to represent possible contaminants and were removed from further analysis. Z-scores were iteratively recalculated until all probable contaminants had been removed.

Stratification of each protein's I:M ratio and its corresponding z-score indicated that numerous proteins in each sample could be considered significantly regulated. For example, of the 1987 proteins identified in the cytosolic run \#1 preparation, 33 were up-regulated at 95% confidence and 14 were also up-regulated at 99.9% confidence (Table [1](#T1){ref-type="table"}). Twenty-two proteins in the same dataset were down-regulated at 95% confidence, and seven of these proteins were also down-regulated at 99.9% confidence. Inspection of protein I:M ratios and z-scores indicated that most proteins differentially regulated at \>95% confidence had I:M ratios altered by \> 1.6-fold. Thus, for proteins observed multiple times, we applied several filtering levels. We considered them significantly regulated if at least one of their observations had a z-score ≥ 1.960σ, if the other observation in the same type of fraction (cytosolic or nuclear) was no more than 0.75σ in the opposite direction, if most of the peptides used to determine the protein regulation were differentially regulated at \>95% confidence, if peptide regulation variability, as measured by standard error of the mean, was relatively small, and if the average I:M ratio was \> 1.6-fold. Application of these filters resulted in removal of several proteins which might otherwise have been considered significantly regulated. For example, mitochondria-associated granulocyte macrophage CSF signaling molecule (gi\|27363461) had an I:M ratio of 1.63 (Additional file [2](#S2){ref-type="supplementary-material"}: Table S1; row 3133) but was excluded because two peptides had measured I:M ratios of \~1.22 and one peptide had a measured ratio of 100 (STD = 12.64). For proteins observed a single time, they were considered significantly regulated if the z-score was ≥ 1.960σ and if the I:M ratios were altered \> 1.6-fold. Using the above criteria, we identified and measured 45 proteins that were significantly up-regulated and 19 proteins that were significantly down-regulated in the cytosolic fraction and 16 proteins that were significantly up-regulated and 9 proteins that were significantly down-regulated in the nuclear fraction (Table [2](#T2){ref-type="table"}).

###### 

Significantly-regulated HeLa cell proteins after T3D infection

                                                                                                                                                                   **Run \# 1 (H:L)**   **Run \# 2 (L:H)**                        
  --------------------------- --------------- --------- ----------------------------------------------------------------------------------------- ------- ------- -------------------- -------------------- --------- ---- ------ ---------
  ***Cytoplasmic***                                                                                                                                                                                                               
  *Up-regulated*                                                                                                                                                                                                                  
  *Measured more than once*                                                                                                                                                                                                       
                              gi\|222136619   MX1       myxovirus resistance protein 1                                                             9.76    0.52            8                   55.9          10.925    23   51.7    7.427
                              gi\|94536771    CCD56     coiled-coil domain containing 56                                                           5.48    1.62            5                   56.6           0.223    3    20.7   15.154
                              gi\|27881482    DDX58     DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide RIG-I                                         4.76    0.83            3                   27.7           7.191    12   23.2    5.203
                              gi\|72534658    IFIT3     interferon-induced protein with tetratricopeptide repeats 3                                4.65    0.39            4                   25.3           7.260    14   46.9    5.067
                              gi\|4826774     ISG15     ISG15 ubiquitin-like modifier                                                              4.60    0.51            14                  47.3           6.164    14   53.9    5.442
                              gi\|116534937   IFIT1     interferon-induced protein with tetratricopeptide repeats 1 isoform 2                      3.80    1.36            2                   40.4          11.782    8    25.1    3.308
                              gi\|156105693   PR285     PPAR-alpha interacting complex protein 285 isoform 1                                       3.45    1.53            2                   22.0           5.564    5    10.6    4.109
                              gi\|153082755   IFIT2     interferon-induced protein with tetratricopeptide repeats 2                                3.37    0.81            3                   33.7           1.291    11   33.1    4.978
                              gi\|6274552     STAT1     signal transducer and activator of transcription 1 isoform alpha                           3.23    0.39            13                  44.4           4.386    34   50.4    4.170
                              gi\|45007007    OAS3      2\'-5\'oligoadenylate synthetase 3                                                         3.00    0.32            4                   19.5           4.560    9    17.3    3.761
                              gi\|208973246   DHPR      quinoid dihydropteridine reductase                                                         2.40    0.48            2                   27.9           0.693    4    20.5    4.171
                              gi\|38201706    SAMD9     sterile alpha motif domain containing 9                                                    2.15    0.48            1                   18.8           2.560    10   15.4    2.648
                              gi\|4506103     E2AK2     eukaryotic translation initiation factor 2-alpha kinase 2                                  1.97    0.72            3                   45.7           2.503    10   16.2    2.374
                              gi\|24307901    IFI35     interferon-induced protein 35                                                              1.92    0.44            3                   29.2           2.119    5    18.4    2.508
                              gi\|166706903   GBP1      guanylate binding protein 1, interferon-inducible, 67 kDa                                  1.85    0.88            5                   25.7           1.682    11   27.2    2.393
                              gi\|5031863     LG3BP     galectin 3 binding protein                                                                 1.81    0.86            6                   19.5           1.731    12   29.2    2.303
                              gi\|22035653    APOL2     apolipoprotein L2                                                                          1.80    0.53            4                   30.3           1.501    6    32.6    2.507
                              gi\|27477136    ZCCHV     zinc finger antiviral protein isoform 1                                                    1.80    0.69            2                   26.2           2.245    16   25.5    2.007
                              gi\|20270303    MIRO2     ras homolog gene family, member T2                                                         1.79    0.92            2                   15.7           9.955    6    15.7   −0.055
                              gi\|4757876     BST2      bone marrow stromal cell antigen 2                                                         1.68    0.38            5                   19.4           1.610    5    18.3    2.201
                              gi\|188528628   PNPT1     polyribonucleotide nucleotidyltransferase 1                                                1.63    0.20            13                  47.6           2.221    24   36.8    1.575
  *Measured once*                                                                                                                                                                                                                 
                              gi\|156415992   ATP8\*    transcription factor B1, mitochondrial                                                     84.09   0.71                                                        2    9.2    15.154
                              gi\|4557321     APOA1     apolipoprotein A-I preproprotein                                                           7.99    0.97                                                        2    23.2    7.089
                              gi\|11342664    MX2       myxovirus resistance protein 2                                                             7.72    0.57                                                        6    11.3    6.972
                              gi\|4502511     CO9       complement component 9 precursor                                                           7.26    4.88                                                        2    5.0     6.760
                              gi\|166706909   IF44L     interferon-induced protein 44-like                                                         6.18    3.89                                                        3    15.9    6.211
                              gi\|74229015    OAS1      2\',5\'-oligoadenylate synthetase 1 isoform 3                                              5.85    0.86                                                        3    11.6    6.024
                              gi\|19923717    DTX3L     deltex 3-like                                                                              3.68    3.31                                                        4    9.7     4.438
                              gi\|74229019    OAS2      2\'-5\'-oligoadenylate synthetase 2 isoform 1                                              3.50    2.14                                                        2    4.9     4.263
                              gi\|41350201    EPN1      epsin 1 isoform c                                                                          3.20    2.53                                                        2    5.5     3.953
                              gi\|5174751     YAP1      Yes-associated protein 1, 65 kD                                                            3.12    1.32                                                        3    7.9     3.867
                              gi\|222831595   DDX60     DEAD (Asp-Glu-Ala-Asp) box polypeptide 60                                                  2.92    1.56                                                        5    7.6     3.636
                              gi\|15208660    RO52      tripartite motif protein 21                                                                2.69    0.63                                                        8    22.7    3.364
                              gi\|110825982   HERC5     hect domain and RLD 5                                                                      2.50    0.86                                                        2    4.7     3.104
                              gi\|4557499     CTBP2     C-terminal binding protein 2 isoform 1                                                     2.49    1.36                                                        7    25.8    3.093
                              gi\|4506191     PSMB10    proteasome beta 10 subunit proprotein                                                      2.21    0.71                                                        2    7.3     2.688
                              gi\|73747915    TAP2      transporter 2, ATP-binding cassette, sub-family B isoform 1                                2.16    0.70                                                        3    10.8    2.615
                              gi\|38016914    SAMH1     SAM domain- and HD domain-containing protein 1                                             2.16    0.48                                                        6    21.7    2.610
                              gi\|126012562   LRP1      low density lipoprotein-related protein 1                                                  2.11    0.60                                                        3    2.9     2.529
                              gi\|4503445     TYPH      endothelial cell growth factor 1 (platelet-derived) precursor                              2.10    0.85                                                        2    18.1    2.504
                              gi\|6912630     IFIT5     interferon-induced protein with tetratricopeptide repeats 5                                2.05    0.63                                                        3    13.9    2.435
                              gi\|112789562   IF16      interferon, gamma-inducible protein 16                                                     1.95    0.64                                                        6    21.8    2.263
                              gi\|45580709    UN93B     unc-93 homolog B1                                                                          1.93    0.77                                                        2    4.2     2.231
                              gi\|9665248     TAP1      transporter 1, ATP-binding cassette, sub-family B                                          1.88    0.78                                                        2    11.8    2.135
                              gi\|52630342    HLA-C     major histocompatibility complex, class I, C precursor                                     1.80    0.34                                                        20   45.4    1.982
  *Down-regulated*                                                                                                                                                                                                                
  *Measured more than once*                                                                                                                                                                                                       
                              gi\|134288865   S4A7      solute carrier family 4, sodium bicarbonate cotransporter, member 7                        0.064   0.21            2                   21.7          −3.832    2    3.8    −15.807
                              gi\|29294627    PPFIBP1   PTPRF interacting protein binding protein 1 isoform 1                                      0.30    0.21            3                   26.5          −10.860   3    11.0    0.328
                              gi\|4506431     RASA1     RAS p21 protein activator 1 isoform 1                                                      0.36    0.06            1                   16.5          −1.418    2    1.8    −4.688
                              gi\|5453704     PRAF3     ADP-ribosylation-like factor 6 interacting protein 5                                       0.56    0.18            4                   40.4          −3.941    2    29.8    0.235
                              gi\|21956645    MTPN      myotrophin                                                                                 0.56    0.08            9                   49.1          −4.823    8    39.0    0.091
  *Measured once*                                                                                                                                                                                                                 
                              gi\|167466177   CDC27     cell division cycle protein 27 isoform 1                                                   0.010   0.36                                                        2    4.0    −15.807
                              gi\|8922549     ASF1B     anti-silencing function 1B                                                                 0.33    0.000                                                       2    23.8   −3.834
                              gi\|33598948    PLCG1     phospholipase C gamma 1 isoform a                                                          0.33    0.34                                                        2    6.9    −3.803
                              gi\|46049063    XPO6      exportin 6                                                                                 0.34    0.05                                                        2    5.2    −3.706
                              gi\|116734706   I2BP2     interferon regulatory factor 2 binding protein 2 isoform B                                 0.36    0.38                                                        3    13.7   −3.517
                              gi\|116686114   FERM1     kindlin-1                                                                                  0.38    0.004                                                       3    12.3   −3.348
                              gi\|5453543     AK1C1     aldo-keto reductase family 1, member C1                                                    0.39    0.05            14                  72.8          −4.099                    
                              gi\|63025188    HERC4     hect domain and RLD 4 isoform a                                                            0.41    0.000                                                       2    2.5    −3.077
                              gi\|14589951    RPAB1     DNA directed RNA polymerase II polypeptide E                                               0.46    0.14                                                        6    21.4   −2.683
                              gi\|51317370    NDUA6     NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6, 14 kDa                              0.47    0.000                                                       2    14.9   −2.637
                              gi\|10190746    RDH14     retinol dehydrogenase 14 (all-trans and 9-cis)                                             0.51    0.38                                                        2    8.6    −2.306
                              gi\|13236559    MMTA2     hypothetical protein LOC79169                                                              0.54    0.01                                                        2    35.0   −2.138
                              gi\|115430235   UHRF1     ubiquitin-like with PHD and ring finger domains 1 isoform 1                                0.55    0.10                                                        2    11.1   −2.105
                              gi\|71773010    AP1G1     adaptor-related protein complex 1, gamma 1 subunit isoform a                               0.55    0.25            4                   22.3          −2.570                    
  ***Nuclear***                                                                                                                                                                                                                   
  *Up-regulated*                                                                                                                                                                                                                  
  *Measured more than once*                                                                                                                                                                                                       
                              gi\|4826774     ISG15     ISG15 ubiquitin-like modifier                                                              4.05    0.40            5                   42.4           4.065    4    23.0    6.275
                              gi\|19923236    SP100     nuclear antigen Sp100 isoform 2                                                            2.96    0.93            4                   18.1           2.812    8    26.2    4.880
                              gi\|112789562   IF16      interferon, gamma-inducible protein 16                                                     2.92    0.40            2                   11.8           2.384    6    19.3    4.879
                              gi\|67089149    PML       promyelocytic leukemia protein isoform 1                                                   2.34    0.60            2                   8.4            2.758    9    21.7    3.496
                              gi\|4757876     BST2      bone marrow stromal cell antigen 2                                                         2.03    0.56            3                   18.3           2.512    2    13.9    2.290
  *Measured once*                                                                                                                                                                                                                 
                              gi\|4503253     DAD1      defender against cell death 1                                                              5.22    0.62            3                   17.7           5.110                    
                              gi\|188219599   NMI       N-myc and STAT interactor                                                                  4.33    1.17                                                        2    16.9    6.125
                              gi\|24307901    IFI35     interferon-induced protein 35                                                              3.60    0.93                                                        3    15.6    5.347
                              gi\|4758024     COIL      coilin                                                                                     2.46    0.83            2                   12.8           2.788                    
                              gi\|5453690     DNJB1     DnaJ (Hsp40) homolog, subfamily B, member 1                                                2.32    0.000                                                       2    11.8    3.499
                              gi\|58530840    DESP      desmoplakin isoform I                                                                      2.09    0.91                                                        3    9.3     3.054
                              gi\|156104878   GLSK      glutaminase                                                                                2.03    0.75                                                        3    4.8     2.931
                              gi\|27477136    ZCCHV     zinc finger antiviral protein isoform 1                                                    1.95    0.74                                                        2    2.2     2.754
                              gi\|4507951     1433F     tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide    1.89    1.06                                                        2    22.8    2.633
                              gi\|5901998     LSM6      Sm protein F                                                                               1.85    0.60                                                        3    56.3    2.538
                              gi\|4506003     PP1A      protein phosphatase 1, catalytic subunit, alpha isoform 1                                  1.70    0.95                                                        4    13.9    2.184
  *Down-regulated*                                                                                                                                                                                                                
  *Measured more than once*                                                                                                                                                                                                       
                              gi\|55953087    NOG1      G protein-binding protein CRFG                                                             0.10    0.21            2                   4.4           −13.385   2    6.3    −1.353
                              gi\|4503453     EDF1      endothelial differentiation-related factor 1 isoform alpha                                 0.63    0.17            4                   28.4          −0.672    4    41.2   −2.991
                              gi\|4507555     LAP2A     thymopoietin isoform alpha                                                                 0.64    0.03            10                  15.3          −2.464    10   12.5   −0.479
  *Measured once*                                                                                                                                                                                                                 
                              gi\|88853069    VTNC      vitronectin precursor                                                                      0.013   0.04            2                   4.8           −13.385                   
                              gi\|25777615    PSD7      proteasome 26S non-ATPase subunit 7                                                        0.39    0.30                                                        3    12.3   −4.046
                              gi\|4757732     AIFM1     programmed cell death 8 isoform 1                                                          0.40    0.18                                                        2    18.4   −3.870
                              gi\|57863257    TCPA      T-complex protein 1 isoform a                                                              0.50    0.04                                                        2    5.2    −2.951
                              gi\|4506701     RS23      ribosomal protein S23                                                                      0.54    0.19                                                        4    32.9   −2.647
                              gi\|151108473   FIS1      tetratricopeptide repeat domain 11                                                         0.63    0.000                                                       2    7.2    −1.990

\*: Obsolete record; removed from NCBI database.

HeLa cell proteins up-regulated by T3D infection are associated with defense responses, immune responses, macromolecular binding, regulation of immune effector processes, and responses to virus
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Proteins, and their levels of regulation, were analyzed several ways. Protein gi numbers were imported into Uniprot (<http://www.uniprot.org/>) and converted into HUGO nomenclature committee (HGNC) identifiers. Significantly up-regulated and down-regulated proteins (95% confidence interval) were then imported into DAVID \[[@B56],[@B58]\] and gene ontologies identified (Figure [3](#F3){ref-type="fig"}).

![**Gene ontology analyses of up-regulated and down-regulated proteins.** Sets of up- and down-regulated proteins identified in Table [2](#T2){ref-type="table"} were separately imported into the DAVID gene ontology suite of programs at the NIAID, gene identifications converted by that program, and ontological functions determined by GOTERM.](1743-422X-10-202-3){#F3}

Up-regulated proteins were assigned to 42 GOTERM biological processes at 95% confidence (Figure [3](#F3){ref-type="fig"}, upper), that included responses to viruses, immune responses, defense responses, regulation of immune effector processes and numerous related processes. Up-regulated proteins were also assigned to 23 functional groups (Figure [3](#F3){ref-type="fig"}, middle) including primarily macromolecular binding and transcription cofactor and nucleotidyltransferase activities.

Protein HGNC identifiers were also uploaded into STRING \[[@B54],[@B55]\] and interactions depicted (Figure [4](#F4){ref-type="fig"}B, left). Many immunomodulatory proteins (ie. MX1, MX2, ISG15, various IFITs and various OAS molecules) form a major interacting cluster and interact either directly or indirectly with numerous other regulated proteins.

![**Molecular pathways of regulated proteins.** Proteins and their levels of regulation were imported into the Ingenuity Pathways Analysis (IPA™) tool and interacting pathways were constructed. **A**, Ontological classifications of all measured proteins (Total) as well as those significantly up- and down-regulated. **B**, Merged networks, determined by uploading the regulated proteins only into STRING \[[@B54],[@B55]\] (left), or by uploading all molecules and their degree of regulation into IPA™ (middle). **C-F**, The top 4 IPA networks, identified at 95% confidence and each of which contained 12 or more "focus" molecules (molecules significantly up- or down-regulated), with pathway names indicated. Solid lines: direct known interactions; dashed lines: suspected or indirect interactions. Significantly regulated proteins identified in either the cytosolic or nuclear fractions were overlaid onto each network; red: significantly up-regulated proteins; pink: moderately up-regulated proteins; grey: proteins identified but not significantly regulated; light green: moderately down-regulated proteins; dark green: significantly down-regulated proteins; white: proteins known to be in network, but not identified in our study.](1743-422X-10-202-4){#F4}

Protein gi numbers and levels of regulation were also imported into the Ingenuity Pathways Analysis (IPA™) tool to build interacting pathways. IPA indicated up-regulated proteins were enriched in cytokines, growth factors, transcription regulators and transmembrane receptors. IPA identified 8 interacting pathways at a confidence level of 95% or greater. Four of these pathways, each with 12 or more "focus" members (significantly up- or down-regulated proteins), shared common members and it was possible to build a single, merged pathway (Figure [4](#F4){ref-type="fig"}B, middle). Other pathways contained 2 or fewer focus molecules. The four major pathways were those involved in antimicrobial response, inflammatory response, infectious diseases, dermatological diseases and conditions, cell-to-cell signaling and interaction, cell cycle, and cell death. Regulated proteins identified in each of the purified cytosolic and nuclear fractions were overlaid onto each network (Figure [4](#F4){ref-type="fig"}C--F). Proteins identified in our analyses as up-regulated and present in the pathways are depicted in shades of red. Some proteins, such as IFI16, ISG15, SP100, and STAT1, were highly regulated in both the cytosol and the nucleus, whereas some, such as IFIT1, Mx1, and TRIM21, were up-regulated in one fraction but not the other. Many of the identified regulated proteins also are involved in several known canonical pathways, including interferon signaling (Figure [5](#F5){ref-type="fig"}), glycogen degradation, pattern recognition receptors, PDGF signaling, antigen presentation, protein ubiquitination, and others (Additional file [3](#S3){ref-type="supplementary-material"}: Figure S2). Many of the highly up-regulated proteins, such as STAT, ISG15 and Mx1 also represent interaction nodes within various pathways, interacting with numerous other proteins. Many of these proteins play important roles in innate immunity. In addition, the Mx proteins, which are large GTPase dynamin-like interferon-induced molecules, are important anti-viral proteins, particularly against RNA viruses \[[@B59],[@B60]\]. These have been identified as up-regulated by various virus infections, including by influenza \[[@B4],[@B7],[@B61]\] and by reoviruses \[[@B62]-[@B64]\].

![**Significantly affected canonical pathway "Interferon signaling", as determined by IPA**^**™**^**analysis.** Red indicates highly up-regulated proteins, light green indicates down-regulated, grey represents not significantly affected, and white represents molecules known to be part of the pathway but not identified by SILAC.](1743-422X-10-202-5){#F5}

To both validate some of the SILAC data, as well as determine temporal expression of various immune-modulated proteins, we harvested T3D-infected HeLa cells at various times, extracted the cytosolic and nuclear fractions, and immuno-probed for various molecules (Figure [6](#F6){ref-type="fig"}). Most Western blot results confirmed the SILAC-determined results (Figure [6](#F6){ref-type="fig"}A). For example, STAT1 was measured as up-regulated in both the cytoplasmic as well as nuclear fractions by SILAC and Western blot of both fractions confirmed these results. A few differences in the specific measured ratios (for example, SILAC indicated STAT1 was up-regulated 3.2--fold in the cytoplasm, but Western blot densitometry suggested the increase was approximately 5--fold) probably reflect different levels of sensitivity of the two assays. In addition, SILAC suggested the relative levels of PARP were essentially unchanged, although Western blot suggested a small decrease in cytoplasmic levels and nuclear fractions demonstrated PARP cleavage (Figure [6](#F6){ref-type="fig"}A). Kinetic analyses revealed more details. Reovirus proteins were not detected at early time points but became detectable by 18 hpi. STAT-1, an important effector protein that plays a key role in numerous canonical pathways (Figure [5](#F5){ref-type="fig"}; Additional file [3](#S3){ref-type="supplementary-material"}: Figure S2), and that was found up-regulated in both the cytoplasmic as well as nuclear fractions by SILAC (Figure [6](#F6){ref-type="fig"}A; Table [2](#T2){ref-type="table"}), was detected in mock-infected cells as well as in infected cells. STAT-1 expression appeared to remain constant until 9 hpi, and then increased from 9 hpi onward, reaching levels about 3-fold higher at 24 hpi in the cytoplasm compared to mock and about 6-fold higher at later time points. Significant STAT1 increases were seen at later times, 18 hpi, in the nucleus (Figure [6](#F6){ref-type="fig"}B). Similarly, expression of Mx1 was detected in mock and at early times in infected cells and began to increase at 9 hpi, reaching \~8-fold higher levels by 24 hpi (Figure [6](#F6){ref-type="fig"}B). Mx1, IFIT1, and ISG15 were detected in cytoplasmic fractions and showed clear up-regulation by 18 hpi (by 9 hpi in the case of Mx1 and IFIT1) (Figure [6](#F6){ref-type="fig"}B), but none of these three proteins were detected in nuclear fractions at any time point up to 48 hpi (data not shown). PARP, cleavage of which serves as an apoptosis marker, demonstrated increased cleavage in both the cytoplasm and the nucleus as early as 2 hpi and this cleavage appeared to wane by about 18-24 hpi, shortly after reovirus proteins became detectable and shortly after the other discussed proteins started to increase, consistent with known interactions between these and other innate immune and inflammatory response molecules \[[@B65]-[@B67]\].

![**Western blot validation of host protein regulation. A**, HeLa cells were mock-infected or infected for 24 h, or **B**, for indicated periods of time, harvested and lysed with 0.5% NP-40 detergent. The cytosolic and nuclear fractions were separately purified, dissolved in SDS electrophoresis sample buffer, and proteins resolved in 10% (**A**), or in 4-16% gradient (**B**) SDS-PAGE, transferred to PVDF, and probed with indicated antibodies. Antibody binding was detected with HRP-conjugated secondary antibodies and ECL, and visualized with an Alpha Innotech FluorChemQ MultiImage III instrument. Molecular weight standards are indicated at left and SILAC-measured ratios are indicated on right in **A**. \*: not detected in indicated fraction; †: based on single peptide only.](1743-422X-10-202-6){#F6}

HeLa cell proteins down-regulated by T3D infection are associated with cell death, macromolecular catabolic processes, and tissue development
---------------------------------------------------------------------------------------------------------------------------------------------

DAVID assigned down-regulated proteins to 18 biological processes at 95% confidence (Figure [3](#F3){ref-type="fig"}, lower), that included ubiquitination regulation, cell adhesion regulation, macromolecular complex assembly and catabolic processes. IPA indicated down-regulated proteins were enriched in translation regulation and transporter factors (Figure [4](#F4){ref-type="fig"}A). Many down-regulated proteins also are related to mitochondrial dysfunction (Additional file [3](#S3){ref-type="supplementary-material"}: Figure S2). Many other proteins, such as EIF4G3, FERMT1, CDC27 and COIL were mapped to the cytoplasmic fractions (Figure [4](#F4){ref-type="fig"}E, F).

An apparent down-regulation in protein levels in either of the sub-cellular fractions examined could represent reduced protein biosynthesis, protein degradation, redistribution of proteins from one fraction to another, or various combinations of the above. Protein redistribution could be manifested by the same protein apparently being up-regulated in one compartment at the same time it appeared down-regulated in the other compartment. While there were numerous proteins that were detected as either up-regulated or down-regulated in one compartment and unaffected in the other compartment (i.e. IFIT3, MX2, PML, RASA1, XPO6) there were very few proteins detected that were up-regulated in one compartment and simultaneously down-regulated in the other. For example coilin (COIL) was found up-regulated about 2.5-fold in purified nuclear fractions, based upon 2 peptides; however, it appeared down-regulated by about 2-fold, but only based upon a single peptide (Additional file [2](#S2){ref-type="supplementary-material"}: Table S1). This molecule is an integral component of nuclear suborganelles called Cajal bodies that play roles in small RNA post-transcriptional modifications \[[@B68],[@B69]\]. More detailed analyses of fates of various proteins, with regards to the possible altered biosynthesis, degradation and redistribution as a result of virus infection, are warranted.

Similarities and differences between HeLa cell and HEK293 cell protein responses to reovirus infection
------------------------------------------------------------------------------------------------------

Transcriptomic responses to T3D infection have been previously reported \[[@B40]\]. That study identified more than 100 interferon- and NF-κB-responsive genes that were either positively or negatively regulated by T3D infection. We identified and measured 30 of these genes' proteins and assessed correlation between the mRNA and protein levels. There was good correlation for some genes and proteins. For example, OAS1 and PML mRNA and protein levels were highly up-regulated, 9 other proteins we identified as up-regulated also had up-regulated mRNA levels, although the degree of up-regulation differed, and some proteins and genes (i.e. UBC and POLD1) were similarly non-regulated or only slightly down-regulated. Analysis of the 30 proteins after assigning proteins and genes to highly-up, slightly-up, non-regulated, slightly-down and highly-down regulated classes resulted in an r^2^ correlation of 0.62 (data not shown), slightly higher than what has been found in other studies that correlate mRNA levels to protein levels \[[@B3],[@B4]\]. Unfortunately, most mRNAs and proteins could not be compared because the other \~70 interferon- and NF-κB-responsive genes reported by O'Donnell et al. \[[@B40]\] were not found by us.

We previously determined HEK293 responses to reovirus T1L infection \[[@B21]\]. That study identified and measured 2992 proteins at 24 hpi, 104 of which were up-regulated and 49 of which were down-regulated. Only 194 (\~ 6.5%) of these same proteins were identified in the current study (Additional file [1](#S1){ref-type="supplementary-material"}: Figure S3). A small number of proteins were similarly regulated by both viruses in both cell types. Most proteins (159-187, depending upon how cutoffs were set) were non-regulated in both cell types, and no proteins were up-regulated in one cell but down-regulated in the other (Additional file [1:](#S1){ref-type="supplementary-material"} Figure S3C). Although there was only \~6.5% overlap between the 2 protein datasets, which could represent differences in the virus used and/or in the type of cell analyzed, many of the highly regulated pathways and processes were similar between the two experimental conditions. For example, regulation of interferon signaling, immunomodulation and responses to virus were highly up-regulated in both studies. Only 5 of the 194 host proteins identified and measured in both the T1L-infected HEK-293 and T3D-infected HeLa cells were significantly regulated. Of these, only 1 (STAT1), discussed in more detail earlier, was significantly regulated by both cell/virus conditions, being up-regulated 2.1-fold in T1L-infected HEK293 cells and up-regulated 3.2-fold in T3D-infected HeLa cells. One other protein (SCO1) was up-regulated 8.4-fold in T1L-infected HEK-293 cells but only moderately up-regulated (1.4-fold, Z-score = 1.088σ) in T3D-infected HeLa cells. SCO1 is a metallochaperone involved in copper homeostasis and found in the mitochondrial intermembrane space \[[@B70]\]. The SCO genes appear evolutionarily conserved \[[@B71]\] and have not yet been reported to have roles in virus replication. Two proteins were significantly up-regulated in one cell type but not regulated in the other. PRKCDBP, a potential tumor suppressor gene \[[@B72]\], and COMT, a degradative methyltransferase \[[@B73]\] that has been associated with cognitive deficits in herpes simplex type 1 virus infections \[[@B74]\], were up-regulated 2.3-, and 3.1-fold, respectively, in T1L-infected HEK-293 cells. However, the COMT ratio is based upon a single measured peptide so less reliable. One protein was significantly down-regulated in one cell type but not regulated in the other. PLCG1, involved in immune regulated signal transduction \[[@B75]\], was down-regulated 3-fold (I:M ratio of 0.33) in T3D-infected HeLa cells. Twenty six other proteins were moderately regulated (Z score 1.000 -- 1.959σ, corresponding to \~ 0.9- -- 2.2-fold up-regulation; or -1.000 -- -1.959σ, corresponding to \~ 0.9- -- 1.6-fold down-regulation \[I:M ratios of 0.63 -- 1.13) (Additional file [3](#S3){ref-type="supplementary-material"}: Table S2). Although measured values were not significant, one additional protein (C2orf43), a gene that has been associated with prostate cancer \[[@B76]\], was moderately down-regulated in both the T1L and T3D infections, with infected:mock values of .66 and 0.61, respectively. A few of these determined values are based upon 1 or 2 peptides. Therefore, additional work is needed to determine whether these apparent similarities and differences are real and virus- and/or cell-specific. We are currently analyzing T1L- and T3D-infected HeLa cells labeled by the iTRAQ reagent to simultaneously compare multiple virus types to mock and to use a complementary approach that may identify additional regulated proteins.

In summary, this non-biased global analysis has identified numerous host proteins significantly affected by reovirus T3D infection. These proteins complement others determined in other studies, fit within numerous inflammatory and innate immune pathways, and will provide the starting point for more detailed kinetic studies, such as initiated herein, as well as studies aimed at delineation of virus-specific pathways.
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###### Additional file 1: Figure S1

Gene ontology distribution of light-labeled proteins in indicated samples collected at 24 hpi from Mock- and T3D-infected HeLa cells; , nuclear-annotated proteins; , non-nuclear-annotated proteins. Total numbers of proteins and percentages indicated within each pie section. **Figure S2.** Additional top-ranked canonical pathways identified by IPA™. Red indicates highly up-regulated proteins, light green indicates down-regulated, grey represents not significantly affected, and white represents molecules known to be part of the pathway but not identified by SILAC. **Figure S3.** Comparison of reovirus-induced protein identifications and regulation in HEK293 cells \[[@B21]\] and in HeLa cells (this study). **A**, Venn diagram of numbers of identified proteins, and their overlap, from the 2 studies. **B**, Dot plot distributions of the Z-scores of each of the 194 proteins identified in both studies. **C**, Comparative distributions of regulated proteins, using Z-score category cutoffs of ± 1.960 (upper value in each cell) and ± 1.000 (lower *italicized* value in each cell). For example, 1 protein (STAT1) had a Z-score \> 1.960 in both the HEK293 and HeLa cell lists and 2 proteins (STAT1 and cytochrome oxidase deficient homolog 1) had Z-scores \> 1.000 in both the HEK293 and HeLa cell lists.
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###### Additional file 2: Table S1

All identified proteins and their associated \# peptides, % coverage, Infected: Mock ratio, and calculated Z-scores a.
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###### Additional file 3: Table S2

Common proteins regulated in either T1L-infected HEK-293 or T3D-infected HeLa cells.
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